AI takes on cancer diagnosis: can a computer match expert pathologists?

NCT ID NCT07307157

ENROLLING_BY_INVITATION Diagnosis Sponsor: Harvard Medical School (HMS and HSDM) Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares a new AI system, called COSMO, against 30 board-certified pathologists to see who can more accurately diagnose brain, lung, and kidney cancers. Both the AI and the pathologists will review the same 300 de-identified tissue images. The goal is to see if AI can help improve cancer diagnosis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: COSMO AI system (digital pathology software)
What this could lead to: If successful, this could show that AI can help pathologists diagnose cancer subtypes more accurately and consistently, potentially speeding up diagnoses.
What could go wrong: This is a small, early-stage study with only 30 pathologists and 300 cases. The AI may not perform as well in real-world settings or on different types of cancer.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRAIN CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain cancer disease kidney cancer lung cancer lung neoplasm renal carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRAIN CANCER LUNG CANCER (DIAGNOSIS) RENAL CANCER

Contacts and locations

Locations

Harvard Medical School

Boston, Massachusetts, 02115, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.